Recently, the overexpression of the ZNF560 protein in osteosarcoma has been associated with poor patient prognosis, while its downregulation reduces tumor cell viability and migration and induces apoptosis, indicating its potential as a predictive biomarker for the disease [66]. Here, ZNF560 is linked to neoplasm.